Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,200 ILa | -0.83% | +6.10% | +159.12% |
May. 01 | InterCure Ltd. Provides Revenue Guidance for the Full Year 2024 | CI |
May. 01 | InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+159.12% | 150M | |
-.--% | 339M | |
+48.56% | 291M | |
+25.77% | 260M | |
+51.16% | 197M | |
+48.02% | 134M | |
-42.86% | 96.96M | |
-40.82% | 121M | |
+7.69% | 93.89M | |
+100.00% | 60.26M |
- Stock Market
- Equities
- INCR Stock
- News InterCure Ltd.
- Novellusdx Ltd. announced that it has received $12.5 million in funding from Pontifax Ltd., InterCure Ltd., OrbiMed Advisors, L.L.C.